APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enterprise Immune System

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Enterprise Immune System Industry Growth and Trends Forecast to 2032

2 May 2026123 pages

Choose your research edition.

Industry ResearchEnterprise Immune System Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Enterprise Immune System Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Enterprise Immune System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enterprise Immune System Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Enterprise Immune System Market Analysis and Forecast 2026-2032227 pages · $4,950 USD

Market perspective

According to APO Research, the global Enterprise Immune System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Enterprise Immune System is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Enterprise Immune System is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Enterprise Immune System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Enterprise Immune System market include Darktrace, Vectra AI, Cylance, Exabeam, Microsoft, IBM Security, Splunk, CrowdStrike and Cisco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Enterprise Immune System market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Enterprise Immune System market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Enterprise Immune System market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Enterprise Immune System.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Enterprise Immune System market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Enterprise Immune System Market by Company

Darktrace

Vectra AI

Cylance

Exabeam

Microsoft

IBM Security

Splunk

CrowdStrike

Cisco

FireEye

Rapid7

Securonix

LogRhythm

Proofpoint

McAfee

Fortinet

Arctic Wolf

Elastic Security

Splunk Phantom

SonicWall

Enterprise Immune System Segment by Type

On-Premise

Cloud-Based

Hybrid

Enterprise Immune System Segment by Application

Large Enterprises

Small and Medium-sized Enterprises (SMEs)

Enterprise Immune System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enterprise Immune System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enterprise Immune System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enterprise Immune System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Enterprise Immune System companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Enterprise Immune System Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Enterprise Immune System Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Enterprise Immune System Market Share by Region (2021-2026) Table 4. Global Enterprise Immune System Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Enterprise Immune System Market Share by Region (2027-2032) Table 6. Global Enterprise Immune System Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Enterprise Immune System Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Enterprise Immune System Market Size Share by Type (2021-2026) Table 9. Global Enterprise Immune System Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Enterprise Immune System Market Size Share Forecasted by Type (2027-2032) Table 11. North America Enterprise Immune System Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Enterprise Immune System Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Enterprise Immune System Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Enterprise Immune System Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Enterprise Immune System Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Enterprise Immune System Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Enterprise Immune System Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Enterprise Immune System Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Enterprise Immune System Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Enterprise Immune System Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Enterprise Immune System Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Enterprise Immune System Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Enterprise Immune System Market Size Share by Application (2021-2026) Table 24. Global Enterprise Immune System Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Enterprise Immune System Market Size Share Forecasted by Application (2027-2032) Table 26. North America Enterprise Immune System Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Enterprise Immune System Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Enterprise Immune System Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Enterprise Immune System Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Enterprise Immune System Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Enterprise Immune System Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Enterprise Immune System Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Enterprise Immune System Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Enterprise Immune System Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Enterprise Immune System Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Enterprise Immune System Industry Trends Table 37. Enterprise Immune System Industry Drivers Table 38. Enterprise Immune System Industry Opportunities and Challenges Table 39. Enterprise Immune System Industry Restraints Table 40. Global Enterprise Immune System Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Enterprise Immune System Revenue Market Share by Company (2021-2026) Table 42. Global Enterprise Immune System Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Enterprise Immune System Key Company Headquarters & Area Served Table 44. Global Enterprise Immune System Company, Product Type & Application Table 45. Global Enterprise Immune System Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Enterprise Immune System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Darktrace Company Information Table 49. Darktrace Business Overview Table 50. Darktrace Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Darktrace Enterprise Immune System Product Portfolio Table 52. Darktrace Recent Development Table 53. Vectra AI Company Information Table 54. Vectra AI Business Overview Table 55. Vectra AI Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Vectra AI Enterprise Immune System Product Portfolio Table 57. Vectra AI Recent Development Table 58. Cylance Company Information Table 59. Cylance Business Overview Table 60. Cylance Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Cylance Enterprise Immune System Product Portfolio Table 62. Cylance Recent Development Table 63. Exabeam Company Information Table 64. Exabeam Business Overview Table 65. Exabeam Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Exabeam Enterprise Immune System Product Portfolio Table 67. Exabeam Recent Development Table 68. Microsoft Company Information Table 69. Microsoft Business Overview Table 70. Microsoft Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Microsoft Enterprise Immune System Product Portfolio Table 72. Microsoft Recent Development Table 73. IBM Security Company Information Table 74. IBM Security Business Overview Table 75. IBM Security Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. IBM Security Enterprise Immune System Product Portfolio Table 77. IBM Security Recent Development Table 78. Splunk Company Information Table 79. Splunk Business Overview Table 80. Splunk Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Splunk Enterprise Immune System Product Portfolio Table 82. Splunk Recent Development Table 83. CrowdStrike Company Information Table 84. CrowdStrike Business Overview Table 85. CrowdStrike Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. CrowdStrike Enterprise Immune System Product Portfolio Table 87. CrowdStrike Recent Development Table 88. Cisco Company Information Table 89. Cisco Business Overview Table 90. Cisco Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Cisco Enterprise Immune System Product Portfolio Table 92. Cisco Recent Development Table 93. FireEye Company Information Table 94. FireEye Business Overview Table 95. FireEye Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. FireEye Enterprise Immune System Product Portfolio Table 97. FireEye Recent Development Table 98. Rapid7 Company Information Table 99. Rapid7 Business Overview Table 100. Rapid7 Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Rapid7 Enterprise Immune System Product Portfolio Table 102. Rapid7 Recent Development Table 103. Securonix Company Information Table 104. Securonix Business Overview Table 105. Securonix Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Securonix Enterprise Immune System Product Portfolio Table 107. Securonix Recent Development Table 108. LogRhythm Company Information Table 109. LogRhythm Business Overview Table 110. LogRhythm Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. LogRhythm Enterprise Immune System Product Portfolio Table 112. LogRhythm Recent Development Table 113. Proofpoint Company Information Table 114. Proofpoint Business Overview Table 115. Proofpoint Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Proofpoint Enterprise Immune System Product Portfolio Table 117. Proofpoint Recent Development Table 118. McAfee Company Information Table 119. McAfee Business Overview Table 120. McAfee Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. McAfee Enterprise Immune System Product Portfolio Table 122. McAfee Recent Development Table 123. Fortinet Company Information Table 124. Fortinet Business Overview Table 125. Fortinet Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Fortinet Enterprise Immune System Product Portfolio Table 127. Fortinet Recent Development Table 128. Arctic Wolf Company Information Table 129. Arctic Wolf Business Overview Table 130. Arctic Wolf Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Arctic Wolf Enterprise Immune System Product Portfolio Table 132. Arctic Wolf Recent Development Table 133. Elastic Security Company Information Table 134. Elastic Security Business Overview Table 135. Elastic Security Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Elastic Security Enterprise Immune System Product Portfolio Table 137. Elastic Security Recent Development Table 138. Splunk Phantom Company Information Table 139. Splunk Phantom Business Overview Table 140. Splunk Phantom Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Splunk Phantom Enterprise Immune System Product Portfolio Table 142. Splunk Phantom Recent Development Table 143. SonicWall Company Information Table 144. SonicWall Business Overview Table 145. SonicWall Enterprise Immune System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. SonicWall Enterprise Immune System Product Portfolio Table 147. SonicWall Recent Development Table 148. North America Enterprise Immune System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Enterprise Immune System Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Enterprise Immune System Market Share by Country (2021-2026) Table 151. North America Enterprise Immune System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Enterprise Immune System Market Share Forecast by Country (2027-2032) Table 153. Europe Enterprise Immune System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Enterprise Immune System Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Enterprise Immune System Market Share by Country (2021-2026) Table 156. Europe Enterprise Immune System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Enterprise Immune System Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Enterprise Immune System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Enterprise Immune System Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Enterprise Immune System Market Share by Country (2021-2026) Table 161. Asia-Pacific Enterprise Immune System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Enterprise Immune System Market Share Forecast by Country (2027-2032) Table 163. Latin America Enterprise Immune System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Enterprise Immune System Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Enterprise Immune System Market Share by Country (2021-2026) Table 166. Latin America Enterprise Immune System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Enterprise Immune System Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Enterprise Immune System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Enterprise Immune System Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Enterprise Immune System Market Share by Country (2021-2026) Table 171. Middle East & Africa Enterprise Immune System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Enterprise Immune System Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Enterprise Immune System Product Image Figure 3. Global Enterprise Immune System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Enterprise Immune System Market Size (2021-2032) & (US$ Million) Figure 5. Global Enterprise Immune System Market Share by Region: 2025 VS 2032 Figure 6. Global Enterprise Immune System Market Share by Region (2021-2032) Figure 7. North America Enterprise Immune System Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Enterprise Immune System Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Enterprise Immune System Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Enterprise Immune System Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Enterprise Immune System Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. On-Premise Image Figure 13. Global On-Premise Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Cloud-Based Image Figure 15. Global Cloud-Based Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Hybrid Image Figure 17. Global Hybrid Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Enterprise Immune System Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Enterprise Immune System Market Share by Type 2025 VS 2032 Figure 20. North America Enterprise Immune System Market Size Share by Type (2021-2032) Figure 21. Europe Enterprise Immune System Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Enterprise Immune System Market Size Share by Type (2021-2032) Figure 23. Latin America Enterprise Immune System Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Enterprise Immune System Market Size Share by Type (2021-2032) Figure 25. Large Enterprises Image Figure 26. Global Large Enterprises Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Small and Medium-sized Enterprises (SMEs) Image Figure 28. Global Small and Medium-sized Enterprises (SMEs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Enterprise Immune System Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Enterprise Immune System Market Share by Application 2025 VS 2032 Figure 31. North America Enterprise Immune System Market Size Share by Application (2021-2032) Figure 32. Europe Enterprise Immune System Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Enterprise Immune System Market Size Share by Application (2021-2032) Figure 34. Latin America Enterprise Immune System Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Enterprise Immune System Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Enterprise Immune System Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Enterprise Immune System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Enterprise Immune System Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Enterprise Immune System Market Share by Country (2021-2032) Figure 41. Europe Enterprise Immune System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Enterprise Immune System Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Enterprise Immune System Market Share by Country (2021-2032) Figure 44. Asia-Pacific Enterprise Immune System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Enterprise Immune System Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Enterprise Immune System Market Share by Country (2021-2032) Figure 47. Latin America Enterprise Immune System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Enterprise Immune System Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Enterprise Immune System Market Share by Country (2021-2032) Figure 50. Middle East & Africa Enterprise Immune System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Enterprise Immune System Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Enterprise Immune System Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • On-Premise
  • Cloud-Based
  • Hybrid
Applications
  • Large Enterprises
  • Small and Medium-sized Enterprises (SMEs)
Companies covered
  • Darktrace
  • Vectra AI
  • Cylance
  • Exabeam
  • Microsoft
  • IBM Security
  • Splunk
  • CrowdStrike
  • Cisco
  • FireEye
  • Rapid7
  • Securonix
  • LogRhythm
  • Proofpoint
  • McAfee
  • Fortinet
  • Arctic Wolf
  • Elastic Security
  • Splunk Phantom
  • SonicWall

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Enterprise Immune System Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Enterprise Immune System Market Size by Region (2021-2032)
  5. 1.4.1 Global Enterprise Immune System Market Size by Region (2021-2026)
  6. 1.4.2 Global Enterprise Immune System Market Size by Region (2027-2032)
  7. 1.5 Key Regions Enterprise Immune System Market Size (2021-2032)
  8. 1.5.1 North America Enterprise Immune System Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Enterprise Immune System Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Enterprise Immune System Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Enterprise Immune System Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Enterprise Immune System Market Size Growth Rate (2021-2032)
2 Enterprise Immune System Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 On-Premise
  3. 2.1.2 Cloud-Based
  4. 2.1.3 Hybrid
  5. 2.2 Global Enterprise Immune System Market Size by Type
  6. 2.2.1 Global Enterprise Immune System Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Enterprise Immune System Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Enterprise Immune System Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Enterprise Immune System Market Size by Regions
  10. 2.3.1 North America Enterprise Immune System Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Enterprise Immune System Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Enterprise Immune System Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Enterprise Immune System Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Enterprise Immune System Market Size Breakdown by Type (2021-2026)
3 Enterprise Immune System Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Large Enterprises
  3. 3.1.2 Small and Medium-sized Enterprises (SMEs)
  4. 3.2 Global Enterprise Immune System Market Size by Application
  5. 3.2.1 Global Enterprise Immune System Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Enterprise Immune System Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Enterprise Immune System Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Enterprise Immune System Market Size by Regions
  9. 3.3.1 North America Enterprise Immune System Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Enterprise Immune System Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Enterprise Immune System Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Enterprise Immune System Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Enterprise Immune System Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Enterprise Immune System Industry Trends
  2. 4.2 Enterprise Immune System Industry Drivers
  3. 4.3 Enterprise Immune System Industry Opportunities and Challenges
  4. 4.4 Enterprise Immune System Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Enterprise Immune System Revenue (2021-2026)
  2. 5.2 Global Enterprise Immune System Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Enterprise Immune System Key Company Headquarters & Area Served
  4. 5.4 Global Enterprise Immune System Company, Product Type & Application
  5. 5.5 Global Enterprise Immune System Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Enterprise Immune System Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Enterprise Immune System Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Enterprise Immune System Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Darktrace
  2. 6.1.1 Darktrace Company Information
  3. 6.1.2 Darktrace Business Overview
  4. 6.1.3 Darktrace Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Darktrace Enterprise Immune System Product Portfolio
  6. 6.1.5 Darktrace Recent Developments
  7. 6.2 Vectra AI
  8. 6.2.1 Vectra AI Company Information
  9. 6.2.2 Vectra AI Business Overview
  10. 6.2.3 Vectra AI Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Vectra AI Enterprise Immune System Product Portfolio
  12. 6.2.5 Vectra AI Recent Developments
  13. 6.3 Cylance
  14. 6.3.1 Cylance Company Information
  15. 6.3.2 Cylance Business Overview
  16. 6.3.3 Cylance Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Cylance Enterprise Immune System Product Portfolio
  18. 6.3.5 Cylance Recent Developments
  19. 6.4 Exabeam
  20. 6.4.1 Exabeam Company Information
  21. 6.4.2 Exabeam Business Overview
  22. 6.4.3 Exabeam Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Exabeam Enterprise Immune System Product Portfolio
  24. 6.4.5 Exabeam Recent Developments
  25. 6.5 Microsoft
  26. 6.5.1 Microsoft Company Information
  27. 6.5.2 Microsoft Business Overview
  28. 6.5.3 Microsoft Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Microsoft Enterprise Immune System Product Portfolio
  30. 6.5.5 Microsoft Recent Developments
  31. 6.6 IBM Security
  32. 6.6.1 IBM Security Company Information
  33. 6.6.2 IBM Security Business Overview
  34. 6.6.3 IBM Security Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 IBM Security Enterprise Immune System Product Portfolio
  36. 6.6.5 IBM Security Recent Developments
  37. 6.7 Splunk
  38. 6.7.1 Splunk Company Information
  39. 6.7.2 Splunk Business Overview
  40. 6.7.3 Splunk Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Splunk Enterprise Immune System Product Portfolio
  42. 6.7.5 Splunk Recent Developments
  43. 6.8 CrowdStrike
  44. 6.8.1 CrowdStrike Company Information
  45. 6.8.2 CrowdStrike Business Overview
  46. 6.8.3 CrowdStrike Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 CrowdStrike Enterprise Immune System Product Portfolio
  48. 6.8.5 CrowdStrike Recent Developments
  49. 6.9 Cisco
  50. 6.9.1 Cisco Company Information
  51. 6.9.2 Cisco Business Overview
  52. 6.9.3 Cisco Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Cisco Enterprise Immune System Product Portfolio
  54. 6.9.5 Cisco Recent Developments
  55. 6.10 FireEye
  56. 6.10.1 FireEye Company Information
  57. 6.10.2 FireEye Business Overview
  58. 6.10.3 FireEye Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 FireEye Enterprise Immune System Product Portfolio
  60. 6.10.5 FireEye Recent Developments
  61. 6.11 Rapid7
  62. 6.11.1 Rapid7 Company Information
  63. 6.11.2 Rapid7 Business Overview
  64. 6.11.3 Rapid7 Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Rapid7 Enterprise Immune System Product Portfolio
  66. 6.11.5 Rapid7 Recent Developments
  67. 6.12 Securonix
  68. 6.12.1 Securonix Company Information
  69. 6.12.2 Securonix Business Overview
  70. 6.12.3 Securonix Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Securonix Enterprise Immune System Product Portfolio
  72. 6.12.5 Securonix Recent Developments
  73. 6.13 LogRhythm
  74. 6.13.1 LogRhythm Company Information
  75. 6.13.2 LogRhythm Business Overview
  76. 6.13.3 LogRhythm Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 LogRhythm Enterprise Immune System Product Portfolio
  78. 6.13.5 LogRhythm Recent Developments
  79. 6.14 Proofpoint
  80. 6.14.1 Proofpoint Company Information
  81. 6.14.2 Proofpoint Business Overview
  82. 6.14.3 Proofpoint Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Proofpoint Enterprise Immune System Product Portfolio
  84. 6.14.5 Proofpoint Recent Developments
  85. 6.15 McAfee
  86. 6.15.1 McAfee Company Information
  87. 6.15.2 McAfee Business Overview
  88. 6.15.3 McAfee Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 McAfee Enterprise Immune System Product Portfolio
  90. 6.15.5 McAfee Recent Developments
  91. 6.16 Fortinet
  92. 6.16.1 Fortinet Company Information
  93. 6.16.2 Fortinet Business Overview
  94. 6.16.3 Fortinet Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Fortinet Enterprise Immune System Product Portfolio
  96. 6.16.5 Fortinet Recent Developments
  97. 6.17 Arctic Wolf
  98. 6.17.1 Arctic Wolf Company Information
  99. 6.17.2 Arctic Wolf Business Overview
  100. 6.17.3 Arctic Wolf Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Arctic Wolf Enterprise Immune System Product Portfolio
  102. 6.17.5 Arctic Wolf Recent Developments
  103. 6.18 Elastic Security
  104. 6.18.1 Elastic Security Company Information
  105. 6.18.2 Elastic Security Business Overview
  106. 6.18.3 Elastic Security Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Elastic Security Enterprise Immune System Product Portfolio
  108. 6.18.5 Elastic Security Recent Developments
  109. 6.19 Splunk Phantom
  110. 6.19.1 Splunk Phantom Company Information
  111. 6.19.2 Splunk Phantom Business Overview
  112. 6.19.3 Splunk Phantom Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Splunk Phantom Enterprise Immune System Product Portfolio
  114. 6.19.5 Splunk Phantom Recent Developments
  115. 6.20 SonicWall
  116. 6.20.1 SonicWall Company Information
  117. 6.20.2 SonicWall Business Overview
  118. 6.20.3 SonicWall Enterprise Immune System Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 SonicWall Enterprise Immune System Product Portfolio
  120. 6.20.5 SonicWall Recent Developments
7 North America
  1. 7.1 North America Enterprise Immune System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Enterprise Immune System Market Size by Country (2021-2026)
  3. 7.3 North America Enterprise Immune System Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Enterprise Immune System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Enterprise Immune System Market Size by Country (2021-2026)
  3. 8.3 Europe Enterprise Immune System Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Enterprise Immune System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Enterprise Immune System Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Enterprise Immune System Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Enterprise Immune System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Enterprise Immune System Market Size by Country (2021-2026)
  3. 10.3 South America Enterprise Immune System Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Enterprise Immune System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Enterprise Immune System Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Enterprise Immune System Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst